share_log

司太立(603520.SH):前三季度净利润897.58万元,同比下降77.17%

Zhejiang Starry Pharmaceutical (603520.SH): The net income in the first three quarters was 8.9758 million yuan, a year-on-year decrease of 77.17%.

Gelonghui Finance ·  Oct 30, 2024 18:21

Gelonghui October 30th| Zhejiang Starry Pharmaceutical (603520.SH) announced the third quarter report for 2024, with a company's revenue in the first three quarters of 1.805 billion yuan, a year-on-year increase of 10.65%; the net income attributable to the shareholders of the listed companies was 8.9758 million yuan, a year-on-year decrease of 77.17%; and the basic earnings per share was 0.02 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment